Ginkgo Bioworks Holdings (DNA) Tax Rate Growth (3y) (2023 - 2026)
Ginkgo Bioworks Holdings (DNA) Tax Rate Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 446.73 Mn | 302.86 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.00 |
| Dec 31, 2025 | -707.00 |
| Sep 30, 2025 | -1.00 |
| Jun 30, 2025 | 46.00 |
| Mar 31, 2025 | -14.00 |
| Dec 31, 2024 | 26.00 |
| Sep 30, 2024 | 46.00 |
| Jun 30, 2024 | -87.00 |
| Mar 31, 2024 | -23.00 |
| Dec 31, 2023 | -391.00 |
| Sep 30, 2023 | 3.00 |